Clinical Trials Directory

Trials / Unknown

UnknownNCT05849363

A Prospective Study of Surgical Treatment Strategies for Goal B Type Basilar Invagination

A Prospective Study of Surgical Treatment Strategies for Goal B Type Basilar Invagination in China

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The etiology of Goal B type basilar invagination (BI) is still not clear, and it may be related to platybasia and short slope. There is no unified standard surgical strategy for Goal B type BI, and different surgical strategies have a great influence on the surgical results of patients. The purpose of our prospective study in China is to (1) further clarify the etiology of Goal B type BI, and (2) improve the surgical outcome in these patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREPosterior fossa decompressionPosterior fossa decompression:Posterior arch of atlas removal, decompression of cerebellum, detection of foramen magnum.
PROCEDUREPosterior Compression-Distraction-Reduction-FixationPosterior Compression-Distraction-Reduction-Fixation:After subperiosteal dissection, the facet joint was exposed. A 2-mm joint "scraper" with sharp edge was inserted into the joint capsule and rotated to remove the articular cartilage. A blunt-edged rotating distractor was then inserted into the joint space, and the facet was sequentially opened with larger and larger blunt rotating distractors. After distraction on one side, an appropriate-sized trial was placed into the contralateral facet, holding the distraction open. This was repeated back and forth with larger trials. These steps were repeated, and the facet joints were distracted up to the pre-planned distance of the odontoid tip above Chamberlain's line.

Timeline

Start date
2023-06-01
Primary completion
2025-06-01
Completion
2025-09-01
First posted
2023-05-08
Last updated
2023-07-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05849363. Inclusion in this directory is not an endorsement.